Corynoline Suppresses Osteoclastogenesis and Attenuates ROS Activities by Regulating NF-κB/MAPKs and Nrf2 Signaling Pathways

J Agric Food Chem. 2024 Apr 10;72(14):8149-8166. doi: 10.1021/acs.jafc.3c07088. Epub 2024 Mar 29.

Abstract

Declining estrogen production in postmenopausal females causes osteoporosis in which the resorption of bone exceeds the increase in bone formation. Although clinical drugs are currently available for the treatment of osteoporosis, sustained medication use is accompanied by serious side effects. Corydalis bungeana Herba, a famous traditional Chinese herb listed in the Chinese Pharmacopoeia Commission, constitutes various traditional Chinese Medicine prescriptions, which date back to thousands of years. One of the primary active components of C. bungeana Turcz. is Corynoline (Cor), a plant isoquinoline alkaloid derived from the Corydalis species, which possesses bone metabolism disease therapeutic potential. The study aimed at exploring the effects as well as mechanisms of Cor on osteoclast formation and bone resorption. TRAcP staining, F-actin belt formation, and pit formation were employed for assessing the osteoclast function. Western blot, qPCR, network pharmacology, and docking analyses were used for analyzing the expression of osteoclast-associated genes and related signaling pathways. The study focused on investigating how Cor affected OVX-induced trabecular bone loss by using a mouse model. Cor could weaken osteoclast formation and function by affecting the biological receptor activators of NF-κB and its ligand at various concentrations. Mechanistically, Cor inhibited the NF-κB activation, and the MAPKs pathway stimulated by RANKL. Besides, Cor enhanced the protein stability of the Nrf2, which effectively abolished the RANKL-stimulated ROS generation. According to an OVX mouse model, Cor functions in restoring bone mass, improving microarchitecture, and reducing the ROS levels in the distal femurs, which corroborated with its in vitro antiosteoclastogenic effect. The present study indicates that Cor may restrain osteoclast formation and bone loss by modulating NF-κB/MAPKs and Nrf2 signaling pathways. Cor was shown to be a potential drug candidate that can be utilized for the treatment of osteoporosis.

Keywords: NF-κB/MAPKs pathway; Nrf2 pathway; corynoline; osteoclast; reactive oxygen species.

MeSH terms

  • Berberine Alkaloids*
  • Bone Resorption* / drug therapy
  • Bone Resorption* / genetics
  • Bone Resorption* / metabolism
  • Cell Differentiation
  • Female
  • Humans
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Osteoclasts
  • Osteogenesis
  • Osteoporosis* / drug therapy
  • Osteoporosis* / genetics
  • Osteoporosis* / metabolism
  • RANK Ligand / genetics
  • RANK Ligand / metabolism
  • Reactive Oxygen Species / metabolism
  • Signal Transduction

Substances

  • NF-kappa B
  • Reactive Oxygen Species
  • corynoline
  • NF-E2-Related Factor 2
  • RANK Ligand
  • Berberine Alkaloids